Experimental COVID-19 mRNA vaccine formulation remains stable after a year at room temperature
MIT News reports that researchers used AI to find stabilizing ingredients for the particles that deliver mRNA. After a year at room temperature, experimental vaccine doses produced immune responses in mice comparable to doses using particles similar to Moderna’s.
TLDR
MIT News reports that researchers used an AI algorithm to select ingredients for the particles that protect and deliver mRNA. They vacuum-dried experimental COVID-19 vaccine doses, then stored them for a year at room temperature or two months at 98°F. In mice, the stored doses produced immune responses comparable to vaccines using particles similar to Moderna’s. The team also tested the formulation in vaccine-delivering microneedle patches.
Combined views
—
First seen 11h ago